LIFECORE BIOMEDICAL, INC. \DE\ — Form SCHEDULE 13D/A
Filed July 2, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Legion Partners Asset Management, LLC filed an amended Schedule 13D/A regarding beneficial ownership in LifeCore Biomedical, Inc. The filing was made on July 2, 2026. The specific details of the ownership stake, share count, or percentage change are not disclosed in the metadata provided.
Why this rating
Schedule 13D/A amendment filing typically routine disclosure; no concrete ownership %, share count, or material transaction details specified in available text.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.